Processa Pharmaceuticals (Nasdaq: PCSA) is a clinical stage drug development company with a pipeline of compounds including next generation chemotherapy. The company is seeking partners for non-core assets including PCS499, a Phase 3 ready compound for rare nephropathies.
Address
HanoverMaryland
United States